Gamma frequency entrainment attenuates amyloid load and modifies microglia

Area of Science:

• Neuroscience
• Cellular Biology
• Biomedical Engineering

Background:

• Gamma oscillations (20-50 Hz) are implicated in neurological disorders, but their direct link to Alzheimer's disease (AD) pathology remains unclear.
• Alzheimer's disease is characterized by amyloid-beta (Aβ) plaque accumulation and cognitive decline.

Purpose of the Study:

• To investigate the role of gamma oscillations in Alzheimer's disease pathogenesis.
• To explore the therapeutic potential of modulating gamma oscillations for AD treatment.

Main Methods:

• Utilized a mouse model of Alzheimer's disease to study gamma oscillations.
• Employed optogenetics to selectively stimulate fast-spiking parvalbumin-positive (FS-PV)-interneurons at 40 Hz.
• Analyzed amyloid-beta levels, gene expression, and microglia morphology.
• Developed and tested a non-invasive 40 Hz light-flickering protocol.

Main Results:

• Behaviorally driven gamma oscillations were reduced before plaque formation and cognitive decline in AD mice.
• Optogenetic 40 Hz stimulation of FS-PV-interneurons decreased Aβ_1-40 and Aβ_1-42 levels.
• 40 Hz light flickering reduced Aβ levels in pre-depositing mice and mitigated plaque load in aged mice.
• Gamma stimulation induced microglial gene expression changes and increased microglia-Aβ co-localization.

Conclusions:

• Gamma rhythms play a crucial role in recruiting neuronal and glial responses to combat Alzheimer's-associated pathology.
• Non-invasive 40 Hz light stimulation shows therapeutic potential for reducing amyloid-beta burden in Alzheimer's disease.